Literature DB >> 3752055

Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study.

F Cambien, A Jacqueson, J L Richard, J M Warnet, P Ducimetiere, J R Claude.   

Abstract

Since the relation between serum triglyceride level and coronary heart disease after adjustment for cholesterol and other risk factors remains controversial, the authors have tested the hypothesis that it could be different according to the level of serum cholesterol, i.e., that there may be an interaction between cholesterol and triglyceride level in prediction of coronary heart disease risk. The data of the Paris Prospective Study were used to carry out a survival analysis, by using the Cox model, with coronary heart disease death as the end point and triglyceride and different risk factors as the predictor variables. In this study, during a mean follow-up of 11.4 +/- 2.2 years, 157 coronary heart disease deaths occurred. Serum triglyceride level is not an independent predictor of coronary heart disease death after adjustment for serum cholesterol. However, when cholesterol, triglyceride, and their interaction term are introduced in the regression equation, all variables contribute significantly to the risk. This is also true when other risk factors are taken into account. As a consequence of this interaction, among the 3,585 subjects with a serum cholesterol level lower than 220 mg/100 ml, serum triglyceride level is an independent predictor of risk, even after adjustment for all other risk factors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3752055     DOI: 10.1093/oxfordjournals.aje.a114435

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

1.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

2.  Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells.

Authors:  C D Byrne; N P Brindle; T W Wang; C N Hales
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

3.  Epidemiologic data on serum lipids and lipoproteins: clinical implications.

Authors:  S W Rabkin
Journal:  CMAJ       Date:  1989-05-15       Impact factor: 8.262

Review 4.  Plasma lipid concentrations: the concept of "normality" and its implications for detection of high cardiovascular risk.

Authors:  B Lewis
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

Review 5.  Hypertriglyceridemia and risk of coronary heart disease.

Authors:  John E Hokanson
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

6.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

7.  Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin.

Authors:  C D Byrne; T W Wang; C N Hales
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 8.  Triglyceride-rich lipoproteins and atherosclerosis.

Authors:  P Schwandt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

9.  Relationship of VLDL receptor and LPL in metabolism of VLDL by macrophage.

Authors:  Y Z Deng; Z C Feng; H X Wang; W G Jiang; Y Q Zhong; C F Wang
Journal:  J Tongji Med Univ       Date:  1991

10.  Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease.

Authors:  S J Pocock; A G Shaper; A N Phillips
Journal:  BMJ       Date:  1989-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.